このエントリーをはてなブックマークに追加


ID 67050
Title Alternative
CDK4/6シグナル伝達は、EGFR変異型非小細胞肺がんにおける上皮成長因子受容体チロシンキナーゼ阻害剤の効果を減弱させる
FullText URL
Author
HARA, Naofumi Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Note
岡山大学審査学位論文
Hara N, Ichihara E, Kano H, Ando C, Morita A, Nishi T, Okawa S, Nakasuka T, Hirabae A, Abe M, Asada N, Ninomiya K, Makimoto G, Fujii M, Kubo T, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer. Transl Lung Cancer Res 2023;12(10):2098-2112. doi: 10.21037/tlcr-23-99
Published Date
2024-03-25
Content Type
Thesis or Dissertation
Grant Number
甲第6972号
Granted Date
2024-03-25
Thesis Type
Doctor of Philosophy in Medical Science
Grantor
岡山大学
Thesis FullText
Thesis or Dissertation (See FullText URL)
Related Url
isVersionOf https://doi.org/10.21037/tlcr-23-99
language
English
File Version
ETD
Grant ID
15301甲第6972号
PubMed ID
Copyright Holders
© Translational Lung Cancer Research.
DOI
License
https://creativecommons.org/licenses/by-nc-nd/4.0/